Covid-19 and HealthCare: find out in the document which are the news and business opportunities in our Country for the sectors of medical devices

Covid-19 e HealthCare: scopri nel documento quali sono le novità e le opportunità di business nel nostro Paese per i settori dei dispositivi farmaceutici, farmaceutico,

As of June 2024, Milan will begin hearing cases regarding patents classified in IPC Section (A), which includes pharmaceuticals.

In its report on the liberalisation of professional services to Parliament and Government, the Italian Competition Authority (the "Authority") has reiterated the importance, as well as the need, to liberalise the distribution of over-the-counter ("OTC") medicines.

The ICA found that Leadiant abused its dominant position in the market for drugs containing chenodeoxycholic acid (CDCA). CDCA is the active ingredient in drugs...

Al via dal 1° gennaio 2023 i nuovi obblighi per i produttori di imballaggio in tema di etichettatura, stabiliti dal decreto legislativo n.116 del 3 settembre 2020 in recepimento della relativa normativa europea.

Italy's payback system for medical devices has been a source of significant upheaval in the sector, with both domestic and international companies closely monitoring developments.

As the Headquarters Agreement for the Milan seat of the Unified Patent Court's central division is signed, confirming that all is in place for the new seat to begin operation this year...

The Proposal attempts to create a robust regulatory framework which will aim at ensuring a greater level of safety of medical devices, enhanced transparency and traceability, reinforcement of the role of notified bodies and of national authorities, and ultimately an improved confidence in EU regulations which greatly suffered after the PIP breast implant scandal.

The long-awaited sentence by the Court of Justice on the Snitem - Syndicat national de l'industrie des technologies médicales (C.329/16) case concerning the ...

The Italian Intellectual Property Code was recently amended and the changes include the addition of a new provision introducing limitations on the right of generics companies to file early Marketing Authorisation (MA) applications.

A few months ago, the Italian Ministry of Health ("Ministry") published new guidelines for the advertising of medical devices (the "Guidelines"), that updated the previous version, dated March 28, 2013.

An overview of the impact of the EU proposal for regulating medical devices in the field of active implantable devices.

On 1 January 2021, important transparency obligations provided for in the Code of Ethics of Confindustria Dispositivi Medici...

The Italian Medicines Agency (AIFA) has issued new guidelines on its future policy on the disclosure of generics (Gxs) applications.

On 12 May 2025, the Italian Communications Authority (AGCOM) adopted the new technical and procedural measures that website operators and video-sharing platforms...

On December 17, 2020, in consideration of the COVID-19 emergency, the Italian Permanent Conference for relations between the State, the Regions and the...

The Situation: On January 31, 2018, the Italian Supreme Court ruled on the first Italian product-related class action promoted by a consumers' association.

Today, as the world marks the 10th anniversary of the UN International Day of Women and Girls in Science, it's a chance to take stock of where we stand. Back in 2015, the United Nations General Assembly.

From June 28, 2025, the accessibility requirements provided for under the European Accessibility Act (the "EAA") have become applicable across the European Union...